key: cord-0760730-buayhz08 authors: Kryshtafovych, Andriy; Moult, John; Billings, Wendy M.; Della Corte, Dennis; Fidelis, Krzysztof; Kwon, Sohee; Olechnovič, Kliment; Seok, Chaok; Venclovas, Česlovas; Won, Jonghun title: Modeling SARS‐CoV‐2 proteins in the CASP‐commons experiment date: 2021-10-05 journal: Proteins DOI: 10.1002/prot.26231 sha: 15d79910f492406ddbe51f152bbd5a98ae284de7 doc_id: 760730 cord_uid: buayhz08 Critical Assessment of Structure Prediction (CASP) is an organization aimed at advancing the state of the art in computing protein structure from sequence. In the spring of 2020, CASP launched a community project to compute the structures of the most structurally challenging proteins coded for in the SARS‐CoV‐2 genome. Forty‐seven research groups submitted over 3000 three‐dimensional models and 700 sets of accuracy estimates on 10 proteins. The resulting models were released to the public. CASP community members also worked together to provide estimates of local and global accuracy and identify structure‐based domain boundaries for some proteins. Subsequently, two of these structures (ORF3a and ORF8) have been solved experimentally, allowing assessment of both model quality and the accuracy estimates. Models from the AlphaFold2 group were found to have good agreement with the experimental structures, with main chain GDT_TS accuracy scores ranging from 63 (a correct topology) to 87 (competitive with experiment). The advent of the COVID-19 crisis spurred major efforts to combat the disease from biologists all over the world. Key to understanding many aspects of the disease mechanism is knowledge of protein structure. Experimental research groups have devoted major effort to this task, but progress has been necessarily slow and more than 2300 amino acids in the Severe Acute Respiratory Syndrome (SARS2) proteins still have no experimental structural coverage. Computed protein structure, while until recently not as accurate as experiment, [1] [2] [3] [4] [5] can nevertheless provide models that may aid in the choice of drug targets, development of vaccine strategies, and insights into viral mechanisms. Early in the pandemic, a number of leading structure modeling research groups, including SWISSMODEL https://swissmodel.expasy. proteins. Because of earlier experimental work on other viruses, particularly SARS, there are homologous structures available for the majority of SARS-CoV-2 proteins, so that useful models can be produced with straightforward template-based methods. [6] [7] [8] [9] [10] [11] The Critical Assessment of Structure Prediction (CASP) initiative engaged the broader modeling community with the aim of producing the best possible structures for the more demanding cases, those without detectable homology to experimentally determined structures, where a community effort was likely to have the most impact. The strategy for this CASP community-wide experiment on modeling SARS-CoV-2 proteins causing the coronavirus disease (CASP-COVID) experiment was to collect models from as many modeling groups as possible and to also solicit community input on evaluating the accuracy of those models, so as to provide the scientific community with the most accurate structures currently possible. The strategy built on three thingsthe existence of a closely knit CASP modeling community, extensive previous CASP results on the reliability of modeling and accuracy estimation methods, [10] [11] [12] [13] [14] [15] [16] [17] and the CASP infrastructure. [18] [19] [20] [21] [22] The CASP-COVID experiment was started on March 9, 2020. The experiment proceeded through six stages, followed by the discussion of the results at the CASP14 conference in December 2020. The stages were as follows: (1) Selection of targets and their analysis, (2) Call for three-dimensional (3D) models, (3) Call for accuracy estimates of the models, (4) Community discussion of the initial results, (5) Call for revised and refined models and accuracy estimates, and (6) Re-release of some targets in CASP14, allowing thorough comparison of models with new experimental data. In addition, there was a post-CASP follow-up to further assess effectiveness of estimates of model accuracy (EMA) methods. There was a strong community response to the call for CASP-COVID participation, with 47 research groups submitting models using a total of 53 3D modeling approaches and 30 accuracy estimation approaches. All groups who submitted at least five models to CASP-COVID and submitted an abstract to CASP14 Abstract book (or had a documented history of participation in CASP) were invited to contribute their method description to this article. The CASP organizers analyzed 29 proteins coded for by the SARS-CoV-2 genome 23 and identified 10 for which part or all of the sequence did not have reliable homologs in the structural database. 24 These were selected as CASP-COVID targets. Table S1 shows graphical representations of the HHsearch 25 sequence searches against the structural database for the selected targets. The targets were analyzed to identify the predicted secondary structure and domain composition, 26 disorder regions, 27 trans-membrane regions 28 and signal peptides. 29 The results of the analysis were posted on the CASP-Commons web site https://predictioncenter. org/caspcommons/target_analysis.cgi. Target sequence information was also posted at https://predictioncenter.org/caspcommons/ targetlist.cgi. Participants were asked to return their models in 3 weeks. Over 1500 3D models were submitted in the first CASP-COVID round. Those included models from the most capable research groups as previously assessed in CASP. 30 The second round ran for 2 weeks in May 2020, immediately before the start of the regular CASP14 experiment. The round consisted of 15 domain-level targets derived from the Round 1 analysis, and seven first-round targets re-released for prediction. Thirty-three groups submitted over 1500 3D models, which were again made public immediately after the deadline. Second round models underwent the same evaluation procedure as those from Round 1. Each of the submitted models in both rounds of modeling was evaluated by accuracy estimation methods developed by the CASP community. Overall, 32 EMA methods were used. The list of participated methods and brief descriptions are provided in the "EMA methods" Supporting Information file. All submitted accuracy estimates are available at https://predictioncenter.org/caspcommons/models_QAresults.cgi. The overall goal of this step was to identify the best models for each target and to estimate their accuracy. This was the first time CASP has addressed this non-trivial task in a real-life situation. Previous regular CASP experiments have shown that EMA methods are overall effective at ranking models by accuracy, but even the bestperforming methods cannot identify the most accurate models for all targets. [41] [42] [43] The CASP-COVID results showed surprisingly high variation in model rankings: for no target was there unanimous agreement on the best 3D model. Rather, for most targets over 10 distinct models were selected as the best (Table STQA1) , creating a problem in recommending which model should be used. To address this issue, the Venclovas group devised a new EMA-jury algorithm that identifies which models were most favored by the EMA methods. The algorithm is described in detail in the Supporting Information. Briefly, the method pools the top 1, top 2,…, top 10 models selected by each EMA ranking into 10 corresponding supersets. If a model is selected by more than one EMA method, it is included multiple times, thus receiving more weight. A consensus structural similarity score is calculated for every model in each superset as an average of CAD-scores 44 from the model's pairwise comparisons with other models in the superset ( Figure SFQA1 ). The maximum of superset-specific consensus scores for a model is recorded as the EMA-jury consensus score. Note that the EMA-jury consensus score quantifies how typical the structure of a model is among the top selections made by the EMA methods rather than the expected level of its structural similarity to the native structure (as individual EMAs do). The EMA-jury scores together with two additional refinement criteria described in the Supporting Information are used for the final selection of models that are most strongly supported by the EMA methods (Table STQA2) . Comparison of the EMA-jury scores with the overall consensus scores computed on full sets of models for each CASP-COVID target shows that the EMA-jury method always selects a subset of models that are more structurally similar within the subset than overall ( Figure 2 ). This indicates that individual EMA rankings are not random and often agree in favoring some structural features. Table STQA3 ). They are very similar to the CAD-score based results with 84% of selected CASP-COVID models being the same, and at least one model in common for every target. To assess the effectiveness of the EMA-jury method, we evaluated its ability to select the best available model from a set of models. Such an analysis requires knowing actual accuracy of models with respect to the target structure. Since only two CASP-COVID targets have been solved so far, we tested the EMA-jury on CASP13 set of server models (almost 11 000 models. on 80 targets). Figure 3 shows that the EMA-jury very often picks the best or nearly the best model, and that the EMA-jury selection is better than simple consensusbased selection. The mean score of the EMA-jury-selected models (0.622) is just slightly behind the mean of the maximum CAD-scores of CASP13 models (0.640) and better than the mean score of models selected with simple-consensus (0.574). The average Z-score (calculated from the distribution of individual EMA scores) of Jury-selected models stands at 1.67, almost twice the value of the average simpleconsensus z score (0.87). Of interest is also the fact that the relative performance of the EMA-jury with respect to simple consensus becomes even more dominant on harder modeling targets. For example, the average EMA-jury z score grows from 1.67 on all CASP13 targets to 2.02 on FM targets, while the corresponding numbers for simple consensus are trending downward: 0.87!0.75. Similar tendencies in scores are observed when analyzing the LDDT-based results ( Figure SFQA5 ). Structures of two CASP-COVID proteins-ORF3a (Target ID: C1905) and ORF8 (Target ID: C1908)-were experimentally solved by the start of CASP14 conference allowing full CASP evaluation of accuracy of the corresponding models against experimental structures. Full-length sequences of both solved targets were released for modeling in both rounds of CASP-COVID, and ORF3a was additionally released in the second round as domain targets C1905-D1 and C1905-D2. Independently, ORF8 was also released in the CASP14 experiment as target T1064. The number of 3D models and EMA estimates collected in the CASP-COVID experiment are summarized in Table 1 . Since there was no significant accuracy improvement in models submitted on full-length targets in the second round, we report only the first-round results for those. From the CASP-COVID and CASP14 evaluation of ORF3a and ORF8 targets, it was immediately apparent that models from DeepMind's AlphaFold2 group were by far the most accurate, consistent with the broader CASP14 results. An interesting question to check was whether accuracy assessment methods can recognize the high accuracy of these models. However, it was impossible to answer this question only with the available data at hand: AlphaFold2 did not submit models in the second round of CASP-COVID (thus no domain-based models for ORF3a), nor did they submit ORF8 models to CASP-COVID (only to CASP14). To adjust for that, we added five AlphaFold models to each of the three CASP-COVID model sets. For ORF8, we added AlphaFold2 (AF2) models submitted on the CASP14 T1064 target. For ORF3a domains, we added AlphaFold models submitted to CASP-COVID (AF-COV) and a-posteriori split into domains. Additional accuracy estimates were solicited on the added AlphaFold models from the authors of 10 established in CASP EMA F I G U R E 2 Maximum consensus scores on CASP-COVID targets (EMA-jury-gray bars; overall consensus-black). Targets are ordered by increasing EMA-jury values. The gray bars are always longer than black ones, indicating that the EMA-jury method successfully selects subsets of models that are more structurally consistent. The vertical dashed line corresponds to the consensus level of 0.6, which represents 100 th percentile of overall consensus scores for all models ( Figure SFQA4 ). CASP, Critical Assessment of Structure Prediction; CASP-COVID, CASP community-wide experiment on modeling SARS-CoV-2 proteins causing the coronavirus disease; EMA, estimates of model accuracy; methods. We discuss here the results for four (out of these 10) that In the post-CASP experiment, three and two out of four EMA groups picked an AF-COV model as top1 for Domains 1 and 2, respectively (pink squares in Figures 5A,B) . Although some EMA groups could discriminate AF-COV models from the others, no group was successful in predicting the correct ranking within the five AF-COV models, although these models are very close. Figure 6 ). The protein was re-released in the regular CASP14 experiment as target T1064 (without 15 N-term residues corresponding to a signal peptide, a feature which almost all CASP-COVID participants ignored, and one cause of poor models). The AlphaFold2 group submitted five high-accuracy predictions for this target. These models (ranging from 64 to 87 GDT_TS) were added to the pool of models for the post-CASP analysis (pink stars in Figure 6 ). The crystal structure of ORF8 was solved as a covalent dimer, while AlphaFold models were monomeric. Despite this, the best monomeric model possesses some important structural features needed for forming the dimeric assembly. In particular, the model correctly reproduces the side chain orientation of the cysteine involved in covalent chain linkage ( Figure SFQA6b ). The average per-residue distance error is similar for the whole structure (1.25 Å) and for the interface region (1.46 Å). In global accuracy estimation, only VoroMQA-dark could identify AF2 models as superior to others (pink squares in Figure 6 ). However, this method did not predict the big difference in absolute model qual- The central goal of CASP is to make assessment of both 3D modeling methods and accuracy estimation methods as rigorous possible, by using a blind prediction system and comparison with experiment. In doing so over 14 rounds, CASP has built a strong community. Further, recent advances in modeling methods show the field has advanced to the point [46] [47] [48] where taking on the most challenging structures should yield useful results. In the past, CASP has also found that properly balanced consensus models can achieve higher accuracy than any of the contributing models. 49 So, there was an obvious appeal to drawing on this community resource to address one aspect of the COVID-19 emergency. Indeed, there was very enthusiastic response and participation from the CASP community. From a more pragmatic point of view, the CASP-COVID modeling initiative also provided a different, real-world application of the modeling methods. Although CASP strives to be as realistic as possible, assessment is done with knowledge of the experimental answers. What can be done when the goal is to generate useful information from models? Since we do not yet know most of the experimental structures of the target proteins, conventional CASP analysis is limited to just two targets. In both cases, correct folds were produced by just one group, AlphaFold2. Based on the most recent CASP14 results, 46,48,50 we expect better performance overall, with at least the majority of the folds correctly predicted by multiple groups. We will have to wait for more experimental results to see if that is true. The most difficult task in generating recommended models turned out to be estimating relative accuracy and, beyond that, absolute accuracy of the submissions. CASP has nurtured the development of accuracy estimation methods for more than a decade, and assessment against experiment has shown impressive progress, with apparently very useful outcomes. [41] [42] [43] 45, [51] [52] [53] However, in the absence of experimental ground truth, initial focus was on agreement between methods and this was low. In turn, this prompted the development of a new method for obtaining consensus accuracy estimates. In spite of these limitations, overall, we regard the experiment as a success, both in terms of bringing the community together to tackle an urgent problem, and in producing a set of potentially useful models. As noted above it was also valuable in drawing attention to issues in real world use that were not apparent in the standard CASP environment. It also once again demonstrated the value of community science. In particular, the experiment was particularly impactful for undergraduate students just beginning in the field, as they were able to better understand the role of their research in a broader scientific context and its potential for benefiting society at large. The CASP experiment is supported by the US National Institute of Major contributions to the main text of the article: • Idea, organization, article concept, coordination and editing-Andriy Kryshtafovych, John Moult, and Krzysztof Fidelis. • Abstract, Section 1, Section 2, and Section 3-Andriy Kryshtafovych and John Moult. • Section 2.4-Kliment Olechnovič and Česlovas Venclovas. • Section 2.7-2.8-Sohee Kwon, Jonghun Won, and Chaok Seok. • Section 1 and Section 3-Wendy M. Billings and Dennis Della Corte. All other authors contributed to the article by providing description of their methods for the Supporting Information. The peer review history for this article is available at https://publons. com/publon/10.1002/prot.26231. The data that supports the findings of this study are available in the Supporting Information of this article. https://orcid.org/0000-0001-5066-7178 Critical assessment of methods of protein structure prediction (CASP)-round XIII Critical assessment of methods of protein structure prediction (CASP)-round XII Critical assessment of methods of protein structure prediction: Progress and new directions in round XI Critical assessment of methods of protein structure prediction (CASP)-round x Critical assessment of methods of protein structure prediction (CASP)-round IX Evaluation of template-based models in CASP8 with standard measures Assessment of template based protein structure predictions in CASP9 Assessment of template-based protein structure predictions in CASP10 Assessment of templatebased modeling of protein structure in CASP11 Evaluation of the template-based modeling in CASP12 Evaluation of template-based modeling in CASP13 Assessment of protein assembly prediction in CASP12 Evaluation of model refinement in CASP13 Assessment of the model refinement category in CASP12 Assessment of protein assembly prediction in CASP13 Assessment of hard target modeling in CASP12 reveals an emerging role of alignment-based contact prediction methods A further leap of improvement in tertiary structure prediction in CASP13 prompts new routes for future assessments New tools and expanded data analysis capabilities at the protein structure prediction center CASP11 statistics and the prediction center evaluation system CASP prediction center infrastructure and evaluation measures in CASP10 and CASP ROLL CASP6 data processing and automatic evaluation at the protein structure prediction center Protein structure prediction center in CASP8 A new coronavirus associated with human respiratory disease in China Protein data bank (PDB): the single global macromolecular structure archive HH-suite3 for fast remote homology detection and deep protein annotation The PSIPRED protein analysis workbench: 20 years on The DISOPRED server for the prediction of protein disorder Advantages of combined transmembrane topology and signal peptide prediction-the Phobius web server SignalP 5.0 improves signal peptide predictions using deep neural networks Estimation of model accuracy in CASP13 Structural modeling of protein complexes: current capabilities and challenges Driven to near-experimental accuracy by refinement via molecular dynamics simulations Highaccuracy refinement using Rosetta in CASP13 Protein structure prediction using Rosetta in CASP12 Protein tertiary structure modeling driven by deep learning and contact distance prediction in CASP13 Deeplearning contact-map guided protein structure prediction in CASP13 Protein structure prediction using multiple deep neural networks in the 13th Critical Assessment of Protein Structure Prediction (CASP13) lDDT: a local superposition-free score for comparing protein structures and models using distance difference tests LGA: a method for finding 3D similarities in protein structures Processing and evaluation of predictions in CASP4 Assessment of protein model structure accuracy estimation in CASP13: challenges in the era of deep learning Assessment of model accuracy estimations in CASP12 Methods of model accuracy estimation can help selecting the best models from decoy sets: assessment of model accuracy estimations in CASP11 CAD-score: a new contact area difference-based function for evaluation of protein structural models Assessment of protein model structure accuracy estimation in CASP14: old and new challenges High-accuracy protein structure prediction in CASP14 Applying and improving AlphaFold at CASP14 Topology evaluation of models for difficult targets in the 14th round of the critical assessment of protein structure prediction (CASP14) net: protein structure prediction meta server Critical Assessment of Methods of Protein Structure Prediction (CASP)-round XIV Evaluation of CASP8 model quality predictions Assessment of the assessment: evaluation of the model quality estimates in CASP10 SUPPORTING INFORMATION Additional supporting information may be found in the online version of the article at the publisher's website. How to cite this article: Kryshtafovych A, Moult J, Billings WM, et al. Modeling SARS-CoV-2 proteins in the CASP-commons experiment AlphaFold team